ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,076,000 | – | 276,485 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,582,275 | $6,060,000 | 2.78% |
| RTW INVESTMENTS, LP | 4,335,746 | $16,606,000 | 1.55% |
| EcoR1 Capital, LLC | 3,281,502 | $12,568,000 | 1.26% |
| DAFNA Capital Management LLC | 246,900 | $946,000 | 0.47% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,415 | $6,761,000 | 0.06% |
| Seelaus Asset Management LLC | 14,300 | $55,000 | 0.06% |
| BAILARD, INC. | 216,000 | $827,000 | 0.06% |
| Hudson Bay Capital Management LP | 650,000 | $2,490,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,040,900 | $15,477,000 | 0.01% |
| Caption Management, LLC | 30,000 | $115,000 | 0.01% |